MRS 1754 is primarily used in research settings to study the role of adenosine receptors in various physiological processes. It acts as a selective antagonist for the A2B adenosine receptor, making it valuable for investigating conditions like inflammation, asthma, and diabetes. By blocking this receptor, researchers can better understand its involvement in immune responses and vascular functions. Additionally, MRS 1754 is utilized in studying cancer progression, as adenosine receptors are known to influence tumor growth and angiogenesis. Its specificity helps in developing targeted therapies for diseases where adenosine signaling plays a critical role.